A

AstriVax

17 employees

AstriVax aims for initial clinical validation of the platform technology, to develop a broad vaccination pipeline.

Basic info

Industry

biotechnology research

Sectors

Medical
Clinical Trials

Date founded

2022

Funding rounds raised

Total raised

$30M

from 7 investors over 7 rounds

A

AstriVax raised $30M on August 25, 2022

Investors: KU Leuven Innovation & Entrepreneurship, V-Bio Ventures, Merieux Equity Partners, Ackermans & van Haaren, Thuja Capital, BNP Paribas Fortis and FundPlus

FAQ